News & Updates

Over the past five years, Toby Fouks has generously supported Brain Canada to advance high-impact brain research across the country.

Each year, over 95,000 Canadians aged 65 and older are diagnosed with dementia—a number expected to rise as our population grows and ages.

Across research, advocacy, and policy, young people are actively shaping the mental health systems we want to see.

Researchers describe being humbled by the heterogeneity of autism and how that translates into the wide range of features, with varied intensities, early in life.

A research team led by Dr. Jonathan Epp, PhD, and Dr. Derya Sargin, PhD, at the University of Calgary, funded by Brain Canada and Women’s Brain Health Initiative (WBHI), has identified a potentially promising target for new Alzheimer’s disease treatments.

Face drooping – Arm weakness – Speech difficulty – Time to call for help! The acronym FAST (Face-Arms-Speech-Time) is both a reminder of the early symptoms of stroke and the urgent action necessary. Acute ischemic stroke (AIS) – the most common form of stroke – occurs when a blood vessel to the brain is blocked, starving part of the brain of oxygen.

The acronym FAST (Face-Arms-Speech-Time) is both a reminder of the early symptoms of stroke and the urgent action necessary.

A Brain Canada-funded platform is enabling new technology for drug discovery, in order to address a wide range of brain diseases and disorders: from epilepsy to autism, and brain tumors to ALS. 

Brain Canada/Bell Let’s Talk study aims to fast-track diagnosis and treatment, delve into the underlying causes, and identify new drug targets

Smartphone app boosts communication between clinician and patient and provides ongoing insights into mood and medication

Brain Canada – Bell Let’s Talk clinical trial will determine if an app-based intervention for mothers can change their children’s brains

Patient recruitment begins for Brain Canada-Bell Let’s Talk research study